Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 76, Issue , 2011, Pages 129-137

  Tontonoz, P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; CHOLESTEROL; CHOLESTEROL ESTER; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; OXYSTEROL; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; REELIN; SERINE PROTEINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN E; PROTEIN; STEROL; UBIQUITIN PROTEIN LIGASE E3; VLDLR PROTEIN;

ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DOWN REGULATION; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; METABOLIC REGULATION; METABOLISM; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TANGIER DISEASE; TRANSCRIPTION REGULATION; ATHEROSCLEROSIS; GENETIC REGULATION; GENETIC TRANSCRIPTION; LIPID HOMEOSTASIS; LIPID STORAGE; PROTEIN DEGRADATION; UBIQUITINATION;

ANIMALS; CHOLESTEROL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; ORPHAN NUCLEAR RECEPTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84867405858     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2011.76.010702     Document Type: Article

References (79)

1. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S, Coskran T, Haghpassand M, Francone OL. 2002. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22: 630-637.
2. Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Bjorkhem I, Pettersson S, Gustafsson JA. 2001. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRb-deficient mice. J Clin Invest 107: 565-573.
3. Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE, et al. 2005. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47: 567-579.
4. Bensinger SJ, Tontonoz P. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454: 470-477.
5. Bischoff ED, Daige CL, Petrowski M, Dedman H, Pattison J, Juliano J, Li AC, Schulman IG. 2010. Non-redundant roles for LXRa and LXRb in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice. J Lipid Res 51: 900-906.
6. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351.
7. Bradley MN, Hong C, Chen M, Joseph SB, Wilpitz DC, Wang X, Lusis AJ, Collins A, Hseuh WA, Collins JL, et al. 2007. Ligand activation of LXRb reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRa and apoE. J Clin Invest 117: 2337-2346.
8. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345.
9. Cameron J, Holla OL, Berge KE, Kulseth MA, Ranheim T, Leren TP, Laerdahl JK. 2008. Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion. Febs J 275: 4121-4133.
10. Castrillo A, Tontonoz P. 2004. Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 20: 455-480.
11. Chasman DI, Pare G, Mora S, Hopewell JC, Peloso G, Clarke R, Cupples LA, Hamsten A, Kathiresan S, Malarstig A, et al. 2009. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 5: e1000730.
12. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. 2006. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. New Engl J Med 354: 1264-1272.
13. Costet P, Luo Y, Wang N, Tall AR. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275: 28240-28245.
14. Dominguez C, Bonvin AM, Winkler GS, van Schaik FM, Timmers HT, Boelens R. 2004. Structural model of the UbcH5B/CNOT4 complex revealed by combining NMR, mutagenesis, and docking approaches. Structure 12: 633-644.
15. Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
16. Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141.
17. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343: 425-430.
18. Goldstein JL, DeBose-Boyd RA, Brown MS. 2006. Protein sensors for membrane sterols. Cell 124: 35-46.
19. Grefhorst A, McNutt MC, Lagace TA, Horton JD. 2008. Plasma PCSK9 preferentially reduces liver LDL receptors in mice. J Lipid Res 49: 1303-1311.
20. Groot PH, Pearce NJ, Yates JW, Stocker C, Sauermelch C, Doe CP, Willette RN, Olzinski A, Peters T, d'Epagnier D, et al. 2005. Synthetic LXR agonists increase LDL in CETP species. J Lipid Res 46: 2182-2191.
21. Hamada K, Shimizu T, Matsui T, Tsukita S, Hakoshima T. 2000. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J 19: 4449-4462.
22. Hiesberger T, Trommsdorff M, HowellBW, Goffinet A, Mumby MC, Cooper JA, Herz J. 1999. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24: 481-489.
23. Hong C, Tontonoz P. 2008. Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors. Curr Opin Genet Dev 18: 461-467.
24. Hong C, Duit S, Jalonen P, Out R, Scheer L, Sorrentino V, Boyadjian R, Rodenburg KW, Foley E, Korhonen L, et al. 2010. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem 285: 19720-19726.
25. Hong C, Walczak R, Dhamko H, Bradley MN, Marathe C, Boyadjian R, Salazar JV, Tontonoz P. 2011. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: Identification of ARL7 as a direct target. J Lipid Res 52: 531-539.
26. Horton JD, Cohen JC, Hobbs HH. 2007. Molecular biology of PCSK9: Its role in LDL metabolism. Trends Biochem Sci 32: 71-77.
27. Hummasti S, Laffitte BA, Watson MA, Galardi C, Chao LC, Ramamurthy L, Moore JT, Tontonoz P. 2004. Liver X receptors are regulators of adipocyte gene expression but not differentiation: Identification of apoD as a direct target. J Lipid Res 45: 616-625.
28. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXRa. Nature 383: 728-731.
29. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, et al. 2008. ApoE promotes the proteolytic degradation of Ab. Neuron 58: 681-693.
30. Joazeiro CA, Weissman AM. 2000. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102: 549-552.
31. Joseph SB, Tontonoz P. 2003. LXRs: New therapeutic targets in atherosclerosis? Curr Opin Pharmacol 3: 192-197.
32. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, et al. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci 99: 7604-7609.
33. Kennedy MA, Venkateswaran A, Tarr PT, Xenarios I, Kudoh J, Shimizu N, Edwards PA. 2001. Characterization of the human ABCG1 gene: Liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem 276: 39438-39447.
34. Kennedy MA, Barrera GC, Nakamura K, Baldan A, Tarr P, Fishbein MC, Frank J, Francone OL, Edwards PA. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 1: 121-131.
35. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, et al. 2000. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci 97: 817-822.
36. Koldamova RP, Lefterov IM, Staufenbiel M, Wolfe D, Huang S, Glorioso JC, Walter M, Roth MG, Lazo JS. 2005. The liver X receptor ligand T0901317 decreases amyloid b production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem 280: 4079-4088.
37. Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P. 2003. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol 23: 2182-2191.
38. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, et al. 2001a. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83.
39. Lee MH, Lu K, Patel SB. 2001b. Genetic basis of sitosterolemia. Curr Opin Lipidol 12: 141-149.
40. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, et al. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272: 3137-3140.
41. Levin N, Bischoff ED, Daige CL, Thomas D, Vu CT, Heyman RA, Tangirala RK, Schulman IG. 2005. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 25: 135-142.
42. Lewis GF, Rader DJ. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circul Res 96: 1221-1232.
43. Liao JK, Laufs U. 2005. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118.
44. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, et al. 2009. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 480-486.
45. Lopez D. 2008. PCSK9: An enigmatic protease. Biochim Biophys Acta 1781: 184-191.
46. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ, Tontonoz P, Edwards PA. 2002. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors a and b. J Biol Chem 277: 31900-31908.
47. Mangelsdorf DJ, Evans RM. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850.
48. Miida T, Hirayama S, Nakamura Y. 2004. Cholesterolindependent effects of statins and new therapeutic targets: Ischemic stroke and dementia. J Atheroscler Thromb 11: 253-264.
49. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, et al. 2005. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122: 707-721.
50. Pearson MA, Reczek D, Bretscher A, Karplus PA. 2000. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101: 259-270.
51. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Pyorala K, Miettinen T, Wilhelmsen L, Olsson AG, et al. 2004. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). 1994. Atherosclerosis Supplements 5: 81-87.
52. Peet DJ, Turley SD, MaW, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRa. Cell 93: 693-704.
53. Poirier S, Mayer G, Benjannet S, Bergeron E, Marcinkiewicz J, Nassoury N, Mayer H, Nimpf J, Prat A, Seidah NG. 2008. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. J Biol Chem 283: 2363-2372.
54. Repa JJ, Mangelsdorf DJ. 2000. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Ann Rev Cell Dev Biol 16: 459-481.
55. Repa JJ, Mangelsdorf DJ. 2002. The liver X receptor gene team: Potential new players in atherosclerosis. Nat Med 8: 1243-1248.
56. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. 2000a. Regulation of mouse sterol regulatory elementbinding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRa and LXRb. Genes Dev 14: 2819-2830.
57. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ. 2000b. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529.
58. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors a and b. J Biol Chem 277: 18793-18800.
59. Rigamonti E, Helin L, Lestavel S, Mutka AL, Lepore M, Fontaine C, Bouhlel MA, Bultel S, Fruchart JC, Ikonen E, et al. 2005. Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circul Res 97: 682-689.
60. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355.
61. Sabol SL, Brewer HB Jr, Santamarina-Fojo S. 2005. The human ABCG1 gene: Identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 46: 2151-2167.
62. Schwartz K, Lawn RM, Wade DP. 2000. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274: 794-802.
63. Scotti E, Hong C, Yoshinaga Y, Tu Y, Hu Y, Zelcer N, Boyadjian R, de Jong PJ, Young SG, Fong LG, et al. 2011. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists. Mol Cell Biol 31: 1885-1893.
64. Shan L, Pang L, Zhang R, Murgolo NJ, Lan H, Hedrick JA. 2008. PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide. Biochem Biophys Res Commun 375: 69-73.
65. Steinberg D, Witztum JL. 2009. Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels. Proc Natl Acad Sci 106: 9546-9547.
66. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
67. Tontonoz P, Mangelsdorf DJ. 2003. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17: 985-993.
68. van Eck M, Bos IS, Kaminski WE, Orso E, Rothe G, Twisk J, Bottcher A, Van Amersfoort ES, Christiansen-Weber TA, Fung-Leung WP, et al. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci 99: 6298-6303.
69. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P. 2000a. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRa. Proc Natl Acad Sci 97: 12097-12102.
70. Venkateswaran A, Repa JJ, Lobaccaro JM, Bronson A, Mangelsdorf DJ, Edwards PA. 2000b. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 275: 14700-14707.
71. Wang N, Lan D, Chen W, Matsuura F, Tall AR. 2004. ATPbinding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci 101: 9774-9779.
72. Weisglass-Volkov D, Calkin C, Tusie-Luna T, Sinsheimer J, Zelcer N, Riba L, Tino A, Ordon{ogonek}ez-Sánchez ML, Cruz-Bautista I, Aguilar-SalinasCA, et al. 2011. The N342SMYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans. J Clin Invest 121: 3062-3071.
73. Willy PJ, Mangelsdorf DJ. 1997. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev 11: 289-298.
74. Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, Cohen JC. 2005. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280: 8742-8747.
75. Zelcer N, Tontonoz P. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116: 607-614.
76. Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P. 2007. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors. Proc Natl Acad Sci 104: 10601-10606.
77. Zelcer N, Hong C, Boyadjian R, Tontonoz P. 2009. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325: 100-104.
78. ZhangDW, Lagace TA, Garuti R, Zhao Z, McDonald M, Horton JD, Cohen JC, Hobbs HH. 2007. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation. J Biol Chem 282: 18602-18612.
79. Zhang L, Fairall L, Goult BT, Calkin AC, Hong C, Millard CJ, Tontonoz P, Schwabe JW. 2011. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. Genes Dev 25: 1262-1274.